Gene: ICA1L
Official Full Name: islet cell autoantigen 1 likeprovided by HGNC
Gene Summary: Predicted to enable protein domain specific binding activity. Predicted to be involved in regulation of transport. Predicted to act upstream of or within spermatid development. Predicted to be located in acrosomal vesicle. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26648 | ICA1L Knockout cell line (HeLa) | Human | ICA1L | 1:3~1:6 | Negative | Online Inquiry |
KO26649 | ICA1L Knockout cell line (HCT 116) | Human | ICA1L | 1:2~1:4 | Negative | Online Inquiry |
KO26650 | ICA1L Knockout cell line (HEK293) | Human | ICA1L | 1:3~1:6 | Negative | Online Inquiry |
KO26651 | ICA1L Knockout cell line (A549) | Human | ICA1L | 1:3~1:4 | Negative | Online Inquiry |
ICA1L Gene Knockout Cell Lines represent a significant advancement in the field of functional genomics, providing researchers with a powerful tool to investigate the role of the ICA1L gene in various biological processes. These cell lines are engineered to have a complete knockout of the ICA1L gene, allowing for the assessment of gene function by observing phenotypic changes and cellular behaviors without the confounding effects of ICA1L expression. The knockout mechanism typically involves CRISPR-Cas9 technology, which ensures precise edits at the genomic level, enhancing the reliability of experimental outcomes.
The key functions of ICA1L are intricately linked to cellular processes such as cell signaling, synaptic function, and neuronal development. By utilizing ICA1L knockout cell lines, researchers are able to elucidate the pathological roles associated with dysregulation of this gene, particularly in neurodegenerative diseases and psychiatric disorders where ICA1L may play a critical signaling role. This application not only accelerates the understanding of complex gene functions but also facilitates the identification of potential therapeutic targets.
One of the specific advantages of our ICA1L Gene Knockout Cell Lines is their unparalleled specificity and consistency, essential factors for generating reproducible data in both research and clinical settings. Unlike alternative methods, such as transient transfection or RNA interference, our knockout cell lines provide a stable genetic model, enabling long-term studies of gene function and drug response.
Our ICA1L Gene Knockout Cell Lines are invaluable for researchers and clinicians seeking to deepen their understanding of gene functions and explore new angles in their studies. They present a unique opportunity to advance knowledge in neurobiology and potential therapeutic developments, making them a critical resource for laboratories focused on genetic research.
As a leader in the biotechnological field, our company is committed to delivering high-quality, scientifically validated products that enhance research capabilities and contribute to breakthroughs in health and medicine. With expertise in genetic engineering and extensive support services, we are dedicated to empowering scientists to achieve their research goals with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.